Archive: December, 2015

 

 

Rex Bionics Positive Interim Data from RAPPER II

27 November 2015: Rex Bionics Plc (AIM: RXB), the pioneer of the REX Robot technology that enhances the mobility of wheelchair users, is pleased to announce positive results from an interim analysis of its RAPPER II clinical trial. RAPPER II (Robot-Assisted PhysiotherapExercises with REX) is a trial to evaluate the safety and feasibility of a set of customised exercises performed in a REX. This first phase of RAPPER II entailed a single visit to the REX clinic, consisting of a walk test and a set of exercises, with immediate post-experience follow-up.  

Read more about Rex Bionics Positive Interim Data from RAPPER II

Nexvet – Animal Health Symposium

Overview of the symposium:

1, The Animal health industry and opportunities for innovation.

2. An overview of Nexvet:

Details of the successful NV-01 pivotal study

Next steps for Nexvet’s development programs...

Read more about Nexvet – Animal Health Symposium